Print this page    •   Back to Web version of article

Companies Weigh Offer of Royalties for AIDS Drugs Aimed at Africa

February 16, 2001

Cipla has offered Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, and Boehringer Ingelheim a proposal in which it would gain the rights to sell generic versions of their patented AIDS drugs in Africa in exchange for a 5 percent royalty fee. If the pharmaceutical companies decline Cipla's offer, the generic maker could turn to compulsory licensing provisions to sell its product in Africa without paying royalties. Foreign aid and revenues could drop if countries grant compulsory licensing rights, reducing the likelihood that such action would be taken. Cipla has also offered to sell an array of AIDS drugs to the group Doctors Without Borders at a considerably lower price than what large pharmaceutical companies are willing to charge to underdeveloped countries.

Other CDC News for February 16, 2001

Companies Weigh Offer of Royalties for AIDS Drugs Aimed at Africa

Drug Makers Are Prodded on Cut-Rate AIDS Medications

TB Patient Appeals for Release: Judge Richard Boylston Put Other Action on Hold Until the Appeal Court Rules

Tuberculosis Rise in Britain Linked to Immigration
Hep-C Plagues Cons: 75 percent of Females Infected at Edmonton Institution for Women

Many HIV Patients Report Use of Alternative Meds

World Bank Warns of AIDS Increase in Cameroon

Nigeria Orders Tests on Local Cure for HIV Virus
Study: HAART Less Costly Than Treatment for AIDS

Previous Updates

Excerpted from:
Wall Street Journal (
02/16/01 P. B1; Pearl, Daniel

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.